Please use the arrows to navigate to the sub pages
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys® technology.
Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
Videos and webcasts
This section contains the latest RNS, news and videos.
James Barder, Chief Executive interview with Proactive Investor’s Andrew Scott
View more videos
Read more News
Full Year Results for the year ended 31 Dec 2019
Notice of Results
Futura to Update on MED3000 at Investor Seminar
Holding(s) in Company
Read more RNS
Our email news alert service provides a subscription to the RNS news from Futura Medical.
Sign up to our Alert Service